Sildenafil ameliorates biomarkers of genotoxicity in an experimental model of spontaneous atherosclerosis

Lipids in Health and Disease

Volumn 12, Issue 1, 2013, Pages

  Rodrigues, Bianca P ^a   Campagnaro, Bianca P ^a,b   Balarini, Camille M ^a   Pereira, Thiago M C ^b,c   Meyrelles, Silvana S ^a   Vasquez, Elisardo C ^a,b,d  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^b UNIVERSIDADE VILA VELHA   (Brazil)

^c Federal Institute of Education   (Brazil)

^d Emescam School of Health Sciences   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CELL DNA; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROETHIDINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; REACTIVE OXYGEN METABOLITE; SILDENAFIL; SUPEROXIDE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; DNA FRAGMENTATION; FLOW CYTOMETRY; GENOTOXICITY; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; TRIACYLGLYCEROL BLOOD LEVEL;

MUS;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; COMET ASSAY; DISEASE MODELS, ANIMAL; DNA FRAGMENTATION; LEUKOCYTES, MONONUCLEAR; LIPOPROTEINS; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OXIDATIVE STRESS; PHOSPHODIESTERASE 5 INHIBITORS; PIPERAZINES; PURINES; SULFONES; SUPEROXIDES; TRIGLYCERIDES;

EID: 84883070309     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-12-128     Document Type: Article

References (60)

1. Oxidative stress and inflammation in heart disease: do antioxidants have a role in treatment and/or prevention? Pashkow FJ, Int J Inflam 2011 2011 9
2. Vascular cell senescence: contribution to atherosclerosis. Minamino T, Komuro I, Circ Res 2007 100 15 26 10.1161/01.RES.0000256837.40544.4a 17204661 (Pubitemid 46074968)
3. Cardiac and vascular phenotypes in the apolipoprotein E-deficient mouse. Vasquez EC, Peotta VA, Gava AL, Pereira TMC, Meyrelles SS, J Biomed Sci 2012 19 22 10.1186/1423-0127-19-22 22330242
4. Aorta of apoE-deficient mice responds to atherogenic stimuli by a prelesional increase and subsequent decrease in the expression of antioxidant enzymes. 't Hoen PAC, Van der Lans CAC, Van Eck M, Bijsterbosch MK, Van Berkel TJC, Twisk J, Circ Res 2003 93 262 269 10.1161/01.RES.0000082978.92494.B1 12829615 (Pubitemid 36993238)
5. Oxidatively damaged DNA and inflammation in the liver of dyslipidemic ApoE-/- mice exposed to diesel exhaust particles. Folkmann JK, Risom L, Hansen CS, Loft S, Møller P, Toxicology 2007 237 134 144 10.1016/j.tox.2007.05. 009 17602821 (Pubitemid 47033949)
6. Cardiovascular autonomic imbalance and baroreflex dysfunction in the apolipoprotein E-deficient mouse. Vasquez EC, Peotta VA, Meyrelles SS, Cell Physiol Biochem 2012 29 635 646 10.1159/000277623 22613964
7. Cytotoxicity and genotoxicity of lipid-oxidation products. Esterbauer H, Am J Clin Nutr 1993 57 779S 786S 8475896 (Pubitemid 23141206)
8. New insights regarding the autoxidation of polyunsaturated fatty acids. Yin H, Porter NA, Antioxid Redox Signal 2005 7 170 184 10.1089/ars.2005.7.170 15650406 (Pubitemid 40187935)
9. Olive oil and oxidative stress. Fitó M, de la Torre R, Covas MI, Mol Nutr Food Res 2007 51 1215 1224 17879994 (Pubitemid 350013169)
10. Inflammation-related gene expression by lipid oxidation-derived products in the progression of atherosclerosis. Leonarduzzi G, Gamba P, Gargiulo S, Biasi F, Poli G, Free Radic Biol Med 2012 52 19 34 10.1016/j.freeradbiomed.2011.09. 031 22037514
11. Effects of aging and hypercholesterolemia on oxidative stress and DNA damage in bone marrow mononuclear cells in apolipoprotein E-deficient mice. Tonini CL, Campagnaro BP, Louro LPS, Pereira TMC, Vasquez EC, Meyrelles SS, Int J Mol Sci 2013 14 3325 3342 10.3390/ijms14023325 23385237
12. Reduction of diabetes-induced oxidative stress by phosphodiesterase inhibitors in rats. Milani E, Nikfar S, Khorasani R, Zamani MJ, Abdollahi M, Comp Biochem Physiol C Toxicol Pharmacol 2005 140 251 255 15907769 (Pubitemid 40720044)
13. Free radicals and antioxidants in normal physiological functions and human disease. Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M, Telser J, Int J Biochem Cell Biol 2007 39 44 84 10.1016/j.biocel.2006.07.001 16978905 (Pubitemid 44566469)
14. Chemical determination of free radical-induced damage to DNA. Dizdaroglu M, Free Radic Biol Med 1991 10 225 242 10.1016/0891-5849(91)90080-M 1650738 (Pubitemid 121003232)
15. A simple technique for quantitation of low levels of DNA damage in individual cells. Singh NP, McCoy MT, Tice RR, Schneider EL, Exp Cell Res 1988 175 184 191 10.1016/0014-4827(88)90265-0 3345800
16. Development and validation of the in vivo alkaline comet assay for detecting genomic damage in marine flatfish. Belpaeme K, Cooreman K, Kirsch-Volders M, Mutat Res 1998 415 167 184 10.1016/S1383-5718(98)00062-X 9714792 (Pubitemid 28352254)
17. Oxidatively damaged DNA in aging dyslipidemic ApoE-/- and wild-type mice. Folkmann JK, Loft S, Møller P, Mutagenesis 2007 22 105 110 10.1093/mutage/gel059 17234687 (Pubitemid 46364515)
18. The proconvulsant effect of sildenafil in mice: role of nitric oxide-cGMP pathway. Riazi K, Roshanpour M, Rafiei-Tabatabaei N, Homayoun H, Ebrahimi F, Dehpour AR, Br J Pharmacol 2006 147 935 943 10.1038/sj.bjp.0706680 16474413
19. Sildenafil decreased cardiac cell apoptosis in diabetic mice: reduction of oxidative stress as a possible mechanism. Ebrahimi F, Shafaroodi H, Asadi S, Nezami BG, Ghasemi M, Rahimpour S, Hashemi M, Doostar Y, Dehpour AR, Can J Physiol Pharmacol 2009 87 556 564 10.1139/Y09-036 19767879
20. Sildenafil restores endothelial function in the apolipoprotein E knockout mouse. Balarini CM, Leal MA, Gomes IBS, Pereira TMC, Gava AL, Meyrelles SS, Vasquez EC, J Transl Med 2013 11 3 10.1186/1479-5876-11-3 23289368
21. Diet-induced atherosclerosis in mice heterozygous and homozygous for apolipoprotein E gene disruption. Zhang SH, Reddick RL, Burkey B, Maeda N, J Clin Invest 1994 94 937 945 10.1172/JCI117460 8083379 (Pubitemid 24286433)
22. Atherosclerosis in mice lacking apo E evaluation of lesional development and progression. Reddick RL, Zhang SH, Maeda N, Arterioscler Thromb 1994 14 141 147 10.1161/01.ATV.14.1.141 8274470
23. Sildenafil increases endothelial progenitor cell function and improves ischemia-induced neovascularization in hypercholesterolemic apolipoprotein E deficient mice. Dussault S, Maingrette F, Ménard C, Michaud S-E, Haddad P, Groleau J, Turgeon J, Perez G, Rivard A, Hypertension 2009 54 1043 1049 10.1161/HYPERTENSIONAHA.109.139451 19770400
24. Mononuclear cell therapy attenuates atherosclerosis in apoE KO mice. Porto ML, Lima LCF, Pereira TMC, Nogueira BV, Tonini CL, Campagnaro BP, Meyrelles SS, Vasquez EC, Lipids Health Dis 2011 10 155 10.1186/1476-511X-10-155 21896159
25. Endothelial dysfunction in the apolipoprotein E-deficient mouse: insights into the influence of diet, gender and aging. Meyrelles SS, Peotta VA, Pereira TMC, Vasquez EC, Lipids Health Dis 2011 10 211 10.1186/1476-511X-10-211 22082357
26. The concurrence of hypercholesterolemia and aging promotes DNA damage in apolipoprotein E-deficient mice. Dalboni SP, Campagnaro BP, Tonini CL, Vasquez EC, Meyrelles SS, Open J Blood Dis 2012 02 51 55 10.4236/ojbd.2012.23010
27. Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Kojda G, Harrison D, Cardiovasc Res 1999 43 562 571 10.1016/S0008-6363(99)00169-8 10690328 (Pubitemid 29369255)
28. Statistics of the comet assay: a key to discriminate between genotoxic effects. Duez P, Dehon G, Kumps A, Dubois J, Mutagenesis 2003 18 159 166 10.1093/mutage/18.2.159 12621072 (Pubitemid 36336533)
29. DNA damage and alterations of gene expression in chronic-degenerative diseases. Izzotti A, Acta Biochim Pol 2003 50 145 154 12673355 (Pubitemid 37034236)
30. Coronary atherosclerosis and somatic mutations: an overview of the contributive factors for oxidative DNA damage. Andreassi MG, Mutat Res 2003 543 67 86 10.1016/S1383-5742(02)00089-3 12510018 (Pubitemid 36050913)
31. DNA strand breaks and base modifications induced by cholesterol hydroperoxides. Ronsein GE, Oliveira MCB, Medeiros MHG, Miyamoto S, Di Mascio P, Free Radic Res 2011 45 266 275 10.3109/10715762.2010.524215 20942561
32. The p53-mediated apoptosis in hypercholesterolemia-induced renal injury of rats. Yao Y, Tian X, Liu X, Shao J, LV Y, J Huazhong Univ Sci Technolog Med Sci 2005 25 408 411 10.1007/BF02828209 16196289
33. Different responses of fluvastatin to cholesterol-induced oxidative modifications in rabbits: evidence for preventive effect against DNA damage. Sevin G, Yasa M, Akcay DY, Kirkali G, Kerry Z, Cell Biochem Funct 2013 31 325 332 10.1002/cbf.2903 23055364
34. Contribution of oxidative stress to endothelial dysfunction in hypertension. Silva BR, Pernomian L, Bendhack LM, Front Physiol 2012 3 441 23227009
35. DNA damage and augmented oxidative stress in bone marrow mononuclear cells from angiotensin-dependent hypertensive mice. Campagnaro BP, Tonini CL, Nogueira BV, Casarini DE, Vasquez EC, Meyrelles SS, Int J Hypertens 2013 2013 10
36. Cardiaca-autonomic imbalance and baroreflex dysfunction in the renovascular angiotensin-dependent hypertensive mouse. Campagnaro BP, Gava AL, Meyrelles SS, Vasquez EC, Int J Hypertens 2012 2012 9
37. Application of the comet assay for assessment of oxidative DNA damage in circulating lymphocytes of Tetralogy of Fallot patients. Srujana K, Begum SS, Rao KN, Devi GS, Jyothy A, Prasad MH, Mutat Res 2010 688 62 65 10.1016/j.mrfmmm.2010.03.009 20227426
38. DNA damage as a new emerging risk factor in atherosclerosis. Andreassi MG, Botto N, Trends Cardiovasc Med 2003 13 270 275 10.1016/S1050-1738(03)00109-9 14522466 (Pubitemid 37159391)
39. DNA damage and repair in atherosclerosis. Mahmoudi M, Mercer J, Bennett M, Cardiovasc Res 2006 71 259 268 10.1016/j.cardiores.2006.03.002 16580654
40. Sildenafil inhibits the formation of superoxide and the expression of gp47phox NAD[P]H oxidase induced by the thromboxane A2 mimetic, U46619, in corpus cavernosal smooth muscle cells. Koupparis AJ, Jeremy JY, Muzaffar S, Persad R, Shukla N, BJU Int 2005 96 423 427 10.1111/j.1464-410X.2005.05643.x 16042742 (Pubitemid 41097694)
41. Sildenafil citrate and sildenafil nitrate (NCX 911) are potent inhibitors of superoxide formation and gp91phox expression in porcine pulmonary artery endothelial cells. Muzaffar S, Shukla N, Srivastava A, Angelini GD, Jeremy JY, Br J Pharmacol 2005 146 109 117 10.1038/sj.bjp.0706305 15980872 (Pubitemid 43086100)
42. The antioxidants and pro-antioxidants network: an overview. Vertuani S, Angusti A, Manfredini S, Curr Pharm Des 2004 10 1677 1694 10.2174/ 1381612043384655 15134565 (Pubitemid 38559778)
43. Antioxidant vitamins in atherosclerosis-animal experiments and clinical studies. Ozkanlar S, Akcay F, Adv Clin Exp Med 2012 21 115 123 23214308
44. The dual personality of NO. Colasanti M, Suzuki H, Trends Pharmacol Sci 2000 21 1998 2001
45. Conflicting effects of nitric oxide and oxidative stress in chronic heart failure: potential therapeutic strategies. Tousoulis D, Papageorgiou N, Briasoulis A, Androulakis E, Charakida M, Tsiamis E, Stefanadis C, Heart Fail Rev 2012 17 65 79 10.1007/s10741-011-9228-4 21293971
46. Pro-oxidative effect of peroxynitrite regarding biological systems: a special focus on high-molar-mass hyaluronan degradation. Hrabarova E, Juranek I, Soltes L, Gen Physiol Biophys 2011 30 223 228 10.4149/gpb-2011-03-223 21952432
47. Pharmacokinetics of sildenafil citrate after single oral doses in healthy male subjects: absolute bioavailability, food effects and dose proportionality. Nichols DJ, Muirhead GJ, Harness JA, Br J Pharmacol 2002 53 5S 12S
48. Sildenafil increases chemotherapeutic efficacy of doxorubicin in prostate cancer and ameliorates cardiac dysfunction. Das A, Durrant D, Mitchell C, Mayton E, Hoke NN, Salloum FN, Park MA, Qureshi I, Lee R, Dent P, Kukreja RC, Proc Natl Acad Sci U S A 2010 107 18202 18207 10.1073/pnas.1006965107 20884855
49. Cyclic nucleotide phosphodiesterases. Essayan DM, J Allergy Clin Immunol 2001 108 671 680 10.1067/mai.2001.119555 11692087 (Pubitemid 33096193)
50. Phosphodiesterase 5 enzyme and its inhibitors: update on pharmacological and therapeutical aspects. Kulkarni SK, Patil CS, Meth Find Exp Clin Pharmacol 2004 26 789 799 10.1358/mf.2004.26.10.872561 (Pubitemid 40193976)
51. Increased phosphodiesterase-5 expression is involved in the decreased vasodilator response to nitric oxide in cirrhotic rat livers. Loureiro-Silva MR, Iwakiri Y, Abraldes JG, Haq O, Groszmann RJ, J Hepatol 2006 44 886 893 10.1016/j.jhep.2006.01.032 16545481
52. Administration of a low dose of sildenafil for 1 week decreases intrahepatic resistance in rats with biliary cirrhosis: the role of NO bioavailability. Lee KC, Yang YY, Huang YT, Lee FY, Hou MC, Lin HC, Lee SD, Clin Sci (Lond) 2010 119 45 55 10.1042/CS20090601
53. Influence of the phosphodiesterase-5 inhibitor, sildenafil, on sensitivity to chemotherapy in breast tumor cells. Di X, Gennings C, Bear HD, Graham LJ, Sheth CM, White KL Jr, Gewirtz DA, Breast Canc Res Treat 2010 124 349 360 10.1007/s10549-010-0765-7
54. Sildenafil accelerates liver regeneration after partial hepatectomy in rats. Yardimci S, Bostanci EB, Ozer I, Dalgic T, Surmelioglu A, Aydog G, Akoglu M, Transplant Proc 2012 44 1747 1750 10.1016/j.transproceed.2012.04.003 22841261
55. Protective effect of sildenafil on liver injury induced by intestinal ischemia/reperfusion. Inan M, Uz YH, Kizilay G, Topcu-Tarladacalisir Y, Sapmaz-Metin M, Akpolat M, Aydogdu N, J Pediatr Surg 2013 48 1707 1715 10.1016/j.jpedsurg.2012.12.054 23932610
56. Comet assay: a reliable tool for the assessment of DNA damage in different models. Dhawan A, Bajpayee M, Parmar D, Cell Biol Toxicol 2009 25 5 32 10.1007/s10565-008-9072-z 18427939
57. Early detection of staurosporine-induced apoptosis by comet and annexin V assays. Godard T, Deslandes E, Lebailly P, Vigreux C, Sichel F, Poul J, Gauduchon P, Histochem Cell Biol 1999 112 155 161 10.1007/s004180050402 10460469 (Pubitemid 29421925)
58. Comet assay and early apoptosis. Choucroun P, Gillet D, Dorange G, Sawicki B, Dewitte JD, Mutat Res 2001 478 89 96 10.1016/S0027-5107(01)00123-3 11406173 (Pubitemid 32530854)
59. Sildenafil inhibits superoxide formation and prevents endothelial dysfunction in a mouse model of secondhand smoke induced erectile dysfunction. Bivalacqua TJ, Sussan TE, Gebska MA, Strong TD, Berkowitz DE, Biswal S, Burnett AL, Champion HC, J Urol 2009 181 899 906 10.1016/j.juro.2008.10.062 19095260
60. Pharmacokinetics and metabolism of sildenafil in mouse, rat, rabbit, dog and man. Walker DK, Ackland MJ, James GC, Muirhead GJ, Rance DJ, Wastall P, Wright PA, Xenobiotica 1999 29 297 310 10.1080/004982599238687 10219969 (Pubitemid 29140098)